BOT 6.25% 34.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-406

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,089 Posts.
    lightbulb Created with Sketch. 269
    So from Botanix announcement IGA score was a secondary endpoint and not required by FDA in the trial...

    Approx 15% of patients achieved IGA success which is clear or almost clear.... Did not see a breakdown here of IGA success in US vs Aus.

    And on average all patients achieved approx 40% reduction in acne...
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.020(6.25%)
Mkt cap ! $617.9M
Open High Low Value Volume
32.5¢ 34.3¢ 32.5¢ $1.814M 5.424M

Buyers (Bids)

No. Vol. Price($)
6 489055 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 340303 4
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.